Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study-Reference-Cited by-同舟云学术

Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study

Published:2016 Issue:4 Volume:13 Page:458
ISSN:1738-3684
Container-title:Psychiatry Investigation
language:en
Short-container-title:Psychiatry Investig

Author:

Woo Young Sup¹,Park Joo Eon²,Kim Do-Hoon³,Sohn Inki²,Hwang Tae-Yeon⁴,Park Young-Min⁵,Jon Duk-In⁶,Jeong Jong-Hyun¹,Bahk Won-Myong¹

Affiliation:

1. Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

2. Department of Psychiatry, Keyo Hospital, Keyo Medical Foundation, Uiwang, Republic of Korea.

3. Department of Psychiatry, Hallym University Medical Center, Chuncheon Sacred Heart Hospital, Chuncheon, Republic of Korea.

4. WHO Collaborating Center of Yongin Mental Hospital, Yongin, Republic of Korea.

5. Department of Psychiatry, Ilsan Paik Hospital, College of Medicine, Inje University, Goyang, Republic of Korea.

6. Department of Psychiatry, College of Medicine, Hallym University, Anyang, Republic of Korea.

Publisher

Korean Neuropsychiatric Association

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference49 articles.

1. The NIMH-MATRICS Consensus Statement on Negative Symptoms

2. Remission criteria for schizophrenia: Evaluation in a large naturalistic cohort

3. One hundred years of schizophrenia: a meta-analysis of the outcome literature

4. Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

5. Prescription Patterns for Patients with Schizophrenia in Korea: A Focus on Antipsychotic Polypharmacy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Efficacy, Safety and Tolerability of Olanzapine and Blonanserin in Patients with Schizophrenia: A Parallel Group Study;Acta Medica Bulgarica;2021-07-01

2. Switching Antipsychotics to Blonanserin in Patients with Schizophrenia: An Open-label, Prospective, Multicenter Study;Clinical Psychopharmacology and Neuroscience;2019-08-31